🍂 Enjoy the Fall Season! 🍂
MindTheDesk

US regulators back multi-cancer blood test – but Hong Kong doctors remain cautious

Global - Asia Archived • September 24, 2026 •
US regulators back multi-cancer blood test – but Hong Kong doctors remain cautious
Efforts to detect multiple cancers through a single blood draw are gathering momentum after US regulators endorsed the technology for the first time, although experts say wider adoption in Hong Kong still faces challenges as doctors remain cautious about its clinical value.
In a landmark decision for the emerging field of multi-cancer early detection (MCED) blood tests, a US Food and Drug Administration (FDA) panel on Thursday voted in favour of US company Grail’s “Galleri test”, recommending it...
Source: South China Morning Post | https://www.scmp.com/rss/91/feed - Read Original
"What you put in is not always what you get out."

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Camping the Easyway"